Valuation: Artivion, Inc.

Market Cap 122.04Cr 106.93Cr 99Cr 91Cr 171.89Cr 12TCr 174.42Cr 1.18TCr 462.85Cr 5.76TCr 458.12Cr 448.25Cr 20TCr P/E 2026 *
300x
P/E 2027 * 61.7x
Enterprise Value 122.04Cr 106.93Cr 99Cr 91Cr 171.89Cr 12TCr 174.42Cr 1.18TCr 462.85Cr 5.76TCr 458.12Cr 448.25Cr 20TCr EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.26x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day-0.88%
1 week-3.30%
Current month+10.73%
1 month+20.31%
3 months-33.05%
6 months-42.17%
Current year-45.45%
1 week 24.55
Extreme 24.55
25.85
1 month 20.73
Extreme 20.73
26.06
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer 69 01/03/2021
Director TitleAgeSince
Director/Board Member 61 01/05/2012
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Date Insider Type Main position Quantity % Market Cap.
11/06/26 Fiscal year

General Counsel

1,32,003 0.2719%
02/06/26 Others

Director

-12,650 0.0261%
01/06/26 Other

General Counsel

1,04,260 0.2148%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-3.30%-20.36%+48.18% 122.04Cr
+0.74%+2.44%-19.54%-11.67% 18TCr
+0.62%-1.38%-10.43%-7.15% 10TCr
+1.50%-0.83%+4.09%+59.54% 5.85TCr
-0.82%-1.93%+38.23%+58.17% 5.14TCr
+0.30%-3.94%-15.86%-45.13% 4.22TCr
-0.86%-10.51% - - 3.14TCr
-1.46%-9.74%-18.56%-44.89% 2.76TCr
-0.12%-1.10%+57.69%-4.69% 2.53TCr
+0.82%-4.19%-6.03%-8.74% 2.05TCr
Average -0.01%+0.88%+1.02%+4.85% 5.38TCr
Weighted average by Cap. +0.37%+3.97%-4.31%+0.58%

Financials

2026 *2027 *
Net sales 49Cr 43Cr 40Cr 36Cr 68Cr 4.69TCr 69Cr 471.17Cr 184.41Cr 2.3TCr 182.53Cr 178.59Cr 7.93TCr 54Cr 47Cr 44Cr 40Cr 76Cr 5.21TCr 77Cr 523.06Cr 204.72Cr 2.55TCr 202.63Cr 198.26Cr 8.8TCr
Net income 44L 38.55L 35.79L 32.89L 61.97L 42Cr 62.88L 4.26Cr 1.67Cr 21Cr 1.65Cr 1.62Cr 72Cr 2.26Cr 1.98Cr 1.84Cr 1.69Cr 3.18Cr 217.95Cr 3.23Cr 22Cr 8.57Cr 106.65Cr 8.48Cr 8.3Cr 368.41Cr
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
23/26/23 $24.87 -1.07% 58,813
22/26/22 $25.14 +0.80% 4,22,282
21/26/21 $24.94 -1.69% 5,35,361
20/26/20 $25.37 +1.24% 4,60,290
17/26/17 $25.06 -2.60% 5,35,319
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
25.14USD
Average target price
42.00USD
Spread / Average Target
+67.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock